634 related articles for article (PubMed ID: 17217864)
1. [Heparin and cancer].
Lykke J
Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
5. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in cancer patients: expanding horizons.
Bergqvist D
Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():19-23. PubMed ID: 12232819
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of postoperative venous thromboembolic complications].
Savel'ev VS; Gologorskiĭ VA; Kirienko AI; Gel'fand BR
Anesteziol Reanimatol; 2000; (4):68-71. PubMed ID: 11014003
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies.
Lecumberri R; Páramo JA; Rocha E
Haematologica; 2005 Sep; 90(9):1258-66. PubMed ID: 16154849
[TBL] [Abstract][Full Text] [Related]
10. [The risk of venous thromboembolism during air travel].
Sanchez O
Rev Prat; 2007 Apr; 57(7):721-3. PubMed ID: 17654820
[No Abstract] [Full Text] [Related]
11. Low-molecular-weight heparins in clinical practice.
Hunt D
South Med J; 1998 Jan; 91(1):2-10. PubMed ID: 9438394
[TBL] [Abstract][Full Text] [Related]
12. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano J; Monreal M
Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
[No Abstract] [Full Text] [Related]
13. [State of the art: low-molecular-weight heparin and beyond].
Cimminiello C; Casali G; Vitali L
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy with low molecular weight heparin in cancer patients.
Petralia P; Kakkar AK
Eur J Med Res; 2004 Mar; 9(3):119-24. PubMed ID: 15096321
[TBL] [Abstract][Full Text] [Related]
15. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
[No Abstract] [Full Text] [Related]
17. Antithrombotic therapy and survival in cancer patients.
Kakkar AK
Best Pract Res Clin Haematol; 2009 Mar; 22(1):147-51. PubMed ID: 19285281
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulants and cancer survival.
Piccioli A; Falanga A; Prandoni P
Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic diseases.
Wakefield TW; Caprini J; Comerota AJ
Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
[No Abstract] [Full Text] [Related]
20. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]